The percentage of persons 67 years of age and older who have evidence of an underlying disease, condition or health concern and who were dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis. Three rates are reported:
-
- A history of falls and a prescription for anticholinergic agents, antiepileptics, antipsychotics, benzodiazepines, nonbenzodiazepine hypnotics or antidepressants (SSRIs, tricyclic antidepressants and SNRIs).
- Dementia and a prescription for antipsychotics, benzodiazepines, nonbenzodiazepine hypnotics, tricyclic antidepressants or anticholinergic agents.
- Chronic kidney disease and prescription for Cox-2 selective NSAIDs or nonaspirin NSAIDs.
Why It Matters?
In older adults, certain medications are associated with increased risk of harm from drug side-effects and drug toxicity and pose a concern for patient safety. Use of potentially inappropriate medications (PIM) in older adults can lead to poor health outcomes, including adverse drug events, confusion, falls, hospitalizations and death.
Older adults, commonly prescribed multiple prescription drugs due to complex medical problems, are increasingly at risk of PIM use. One study found that each additional drug an individual used during the year was associated with a 5.2 percentage point increase in their probability of using a PIM1. PIM use in older adults has been connected to significantly longer hospital stay lengths and increased hospitalization costs2, as well as to increased risk of death3. Use of specific PIMs such as hypnotics, including benzodiazepine receptor agonists and nonsteroidal anti‐inflammatory drugs (NSAIDS) can also result in increased risk of delirium, falls, fractures, gastrointestinal bleeding and acute kidney injury4.
The DDE and DAE measures are based on recommendations in the American Geriatrics Society (AGS) 2023 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults5. The AGS Beers Criteria are one of the most widely used sources about the safety of medication prescribing in older adults. They include evidence-based recommendations on medications that are potentially harmful in all older adults and those with specific diseases or conditions. The development of the 2023 Updated Beers Criteria was based on a systematic literature review and discussion by a panel of experts in geriatric care and pharmacotherapy. NCQA’s measurement advisory panels also provide guidance on the specific conditions and medications included in the DDE and DAE measures.
Preventing poor health effects from use of PIMs is a growing concern with the increasing population of adults over 65 and rising prescription medication use, particularly as the hospitalization rate for adverse drug events among adults 65 or older is 7 times higher than that of adults younger than 656 7.
Interventions focused on reducing the use of PIMs can lower the incidence of these poor health outcomes. Prescription benefit plans often require preauthorization of specific medications, to limit the use of PIMs in older adults. Additional interventions have included direct patient education8 and the use of computer-based reminder systems. Computerized prescribing, combined with clinical decision support systems, can alert a physician when they are attempting to prescribe a PIM to an older adult.
Studies have found these systems to be effective in reducing prescribing of PIMs9 10 11. Studies have also shown that integration of the Beers Criteria (which list PIMs) in electronic health records can provide instant feedback and medication alternatives when PIMs are originally selected12.
Reducing use of PIMs in older adults also represents an opportunity to lower the costs associated with harm from medications (e.g., hospitalizations for drug toxicity) and encourages clinicians to consider safer alternatives. Adverse drug events (ADE) occur often in hospitals and contribute to longer length of stay and increased risk of mortality. Older adults make up approximately 35% of all inpatient stays but contribute to approximately 53% of inpatient stays complicated by ADEs13. The impact and the management of ADEs is complex and, as one study found, may cost up to $30.1B annually in the United States14. Preventable medication errors are estimated to impact more than 7 million patients, contribute to 7,000 deaths and, as another study found, cost almost $21B in direct medical costs across all care settings annually in the U.S15.
Historical Results – National Averages
Get Access to the Historical Results
By completing the form below, you’ll gain free access to national performance data.
"*" indicates required fields
References
- Miller, G.E., E.M. Sarpong, A.J. Davidoff, E.Y. Yang, N. Brandt, D.M. Flick. 2017. “Determinants of Potentially Inappropriate Medication Use Among Community-Dwelling Older Adults.” Health Services Research 52(4):1534–49.
- Hagstrom, K., M. Nailor, M. Lindberg, L. Hobbs, and D.M. Sobieraj. 2015. “Association Between Potentially Inappropriate Medication Use in Elderly Adults and Hospital‐Related Outcomes.” Journal of the American Geriatrics Society 63(1), 185–6.
- Lau, D.T., J.D. Kasper, D.E. Potter, A. Lyles. 2004. “Potentially Inappropriate Medication Prescriptions Among Elderly Nursing Home Residents: Their Scope and Associated Resident and Facility Characteristics.” Health Services Research 39(5): 1257–76.
- Merel, S.E., and D.S. Paauw. 2017. “Common Drug Side Effects and Drug‐Drug Interactions in Elderly Adults in Primary Care.” Journal of the American Geriatrics Society 65(7), 1578–85.
- American Geriatrics Society Beers Criteria Update Expert Panel. 2023. “American Geriatrics Society 2023 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.” Journal of the American Geriatrics Society 71(7), 2052–81.
- Charlesworth, C.J., E. Smit, D.S. Lee, F. Alramadhan, and M. Odden. 2015. “Polypharmacy Among Adults Aged 65 Years and Older in the United States: 1988–2010.” Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences 70(8), 989–95.
- Shehab, N., M.C. Lovegrove, A.I. Geller, K.O. Rose, N.J. Weidle, and D.S. Budnitz. 2016. “US Emergency Department Visits for Outpatient Adverse Drug Events, 2013–2014.” JAMA 316(20), 2115–25.
- Tannenbaum, C., P. Martin, R. Tamblyn, A. Benedetti, S. Ahmed. 2014. “Reduction of Inappropriate Benzodiazepine Prescriptions Among Older Adults Through Direct Patient Education: The EMPOWER Cluster Randomized Trial.” JAMA Internal Medicine 174: 890–8.
- Agostini, J.V., Y. Zhang, S.K. Inouye. 2007. “Use of a Computer‐Based Reminder to Improve Sedative–Hypnotic Prescribing in Older Hospitalized Patients.” Journal of the American Geriatrics Society 55(1): 43–8.
- Terrell, K.M., A.J. Perkins, P.R. Dexter, S.L. Hui, C.M. Callahan, D.K. Miller. 2009. “Computerized Decision Support to Reduce Potentially Inappropriate Prescribing to Older Emergency Department Patients: A Randomized, Controlled Trial.” Journal of the American Geriatrics Society 57(8): 1388–94.
- Iankowitz, N., M. Dowden, S. Palomino, H. Uzokwe, P. Worral. 2012. “The Effectiveness of Computer System Tools on Potentially Inappropriate Medications Ordered at Discharge for Adults Older Than 65 Years of Age: A Systematic Review. JBI Library of Systematic Reviews 10(13): 798–83
- Fick, D.M., and T.P. Selma. 2012 American Geriatrics Society Beers Criteria: New Year, New Criteria, New Perspective. The American Geriatrics Society.
- U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion (HHS). 2014. National Action Plan for Adverse Drug Event Prevention.
- Sultana, J., P. Cutroneo, G. Trifiro. 2013. “Clinical and Economic Burden of Adverse Drug Reactions.” Journal of Pharmacology and Pharmacotherapeutics 4(1):S73–7.
- Lahue, B.J., B. Pyenson, K. Iwasaki, H.E. Blumen, S. Forray, and J.M. Rothschild. 2012. “National Burden of Preventable Adverse Drug Events Associated with Inpatient Injectable Medications: Healthcare And Medical Professional Liability Costs.” American Health & Drug Benefits 5(7), 1.
-
Save
Save your favorite pages and receive notifications whenever they’re updated.
You will be prompted to log in to your NCQA account.
Save your favorite pages and receive notifications whenever they’re updated.
You will be prompted to log in to your NCQA account.
-
Email
Share this page with a friend or colleague by Email.
We do not share your information with third parties.
Share this page with a friend or colleague by Email.
We do not share your information with third parties.
-
Print
Print this page.
Print this page.